These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24490472)

  • 41. [Hydrogels: properties and application in the technology of drug form. II. Possibilities of use of hydrogels as active substance carriers].
    Pluta J; Karolewicz B
    Polim Med; 2004; 34(3):63-81. PubMed ID: 15631157
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current advances in sustained-release systems for parenteral drug delivery.
    Shi Y; Li LC
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1039-58. PubMed ID: 16296808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
    Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Local adverse reactions associated with parenteral administration of drugs].
    Bjånes TK
    Tidsskr Nor Laegeforen; 2011 Mar; 131(5):472-4. PubMed ID: 21383802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chitosan: a unique polysaccharide for drug delivery.
    Felt O; Buri P; Gurny R
    Drug Dev Ind Pharm; 1998 Nov; 24(11):979-93. PubMed ID: 9876553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Physicochemical incompatibilities of injectable drugs].
    Hoffman M; Hazebroucq G
    Sem Hop; 1983 Feb; 59(8):541-7. PubMed ID: 6302899
    [No Abstract]   [Full Text] [Related]  

  • 47. Diclofenac sodium multisource prolonged release tablets--a comparative study on the dissolution profiles.
    Bertocchi P; Antoniella E; Valvo L; Alimonti S; Memoli A
    J Pharm Biomed Anal; 2005 Apr; 37(4):679-85. PubMed ID: 15797788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on the absorption of practically water-insoluble drugs following injection. IV. An approach for predicting relative intramuscular absorption rates of a drug in oily solution, aqueous suspension and aqueous surfactant solution in rats.
    Hirano K; Yamada H
    Chem Pharm Bull (Tokyo); 1981 May; 29(5):1410-5. PubMed ID: 7296708
    [No Abstract]   [Full Text] [Related]  

  • 49. [Pharmaceutical suspensions, an effective drug form].
    Bashuara GS; Safiulina ZR; Pertsev IM; Duchidze NV
    Farm Zh; 1975; 30(6):27-34. PubMed ID: 765146
    [No Abstract]   [Full Text] [Related]  

  • 50. In situ gelling hexagonal phases for sustained release of an anti-addiction drug.
    Phelps J; Bentley MV; Lopes LB
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):391-8. PubMed ID: 21703826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics and bioavailability of four modified-release ursodeoxycholic acid preparations for once-a-day administration.
    Simoni P; Sabatini L; Baraldini M; Mirasoli M; Roda A; Roda E
    Int J Clin Pharmacol Res; 2002; 22(2):37-45. PubMed ID: 12503774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hybrid insulin cocrystals for controlled release delivery.
    Brader ML; Sukumar M; Pekar AH; McClellan DS; Chance RE; Flora DB; Cox AL; Irwin L; Myers SR
    Nat Biotechnol; 2002 Aug; 20(8):800-4. PubMed ID: 12134168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Starch and its derivatives as excipients in oral and parenteral drug form technology].
    Zgoda MM; Kolodziejczyk MK; Nachajski MJ
    Polim Med; 2009; 39(1):31-45. PubMed ID: 19580171
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of polysorbates on drug release from wax matrices.
    Dredán J; Zelkó R; Bihari E; Rácz I; Gondár E
    Drug Dev Ind Pharm; 1998 Jun; 24(6):573-6. PubMed ID: 9876626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood glucose profiles in diabetic rodents using different insulin preparations.
    Schneider S; Weber R; Luippold G
    Arzneimittelforschung; 2004; 54(12):842-6. PubMed ID: 15646368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Scleroglucan sustained release oral preparations. Part II. Effects of additives.
    Alhaique F; Beltrami E; Riccieri FM; Santucci E; Touitou E
    Drug Des Deliv; 1990 Mar; 5(3):249-57. PubMed ID: 1670505
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dissociation constant of chlordiazepoxide in montmorillonite suspension and its pharmaceutical application for a controlled-release dosage form.
    el-Sayed AM; Ismael A el-M ; Assi A el-A
    Acta Pharm Hung; 1993 Sep; 63(5):257-66. PubMed ID: 8249610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Thermosensitive polymers in drug form technology. I. Classification and characteristics].
    Pluta J; Karolewicz B
    Polim Med; 2008; 38(1):3-14. PubMed ID: 18661702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology.
    Merisko-Liversidge E; Liversidge GG
    Adv Drug Deliv Rev; 2011 May; 63(6):427-40. PubMed ID: 21223990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.